Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2- advanced breast cancer: a matching-adjusted indirect comparison.
Hope S RugoVictoria HarmerJoyce O'ShaughnessyKomal JhaveriSara M TolaneyFatima CardosoAditya BardiaVikalp Kumar MaheshwariSandeep TripathiSina HaftchenaryPurnima PathakPeter A FaschingPublished in: Therapeutic advances in medical oncology (2023)
NCT01958021 (MONALEESA-2) and NCT02246621 (MONARCH 3).
Keyphrases